Study Details
Full Title
[C6461003] An Interventional, Phase 3, Double-Blind, Randomized Study to Evaluate the Efficacy and Safety of PF-08634404 in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Treatment-Naïve Participants with Metastatic Colorectal Cancer
Principal Investigator
Aman
Opneja
Protocol Number
PRO00119226
NCT ID
NCT07222800
Phase
III
Enrollment Status
Open to Enrollment